Skip to main content
. Author manuscript; available in PMC: 2015 Nov 7.
Published in final edited form as: Vaccine. 2012 Nov 20;30(0 5):F123–F138. doi: 10.1016/j.vaccine.2012.04.108

Figure 1.

Figure 1

Rate reduction and vaccine efficacy are time dependent variables. Time-to-event curves for acquisition of HPV6/11/16/18-related CIN3/AIS in Gardasil® (Merck & Co., Whitehouse Station, NJ USA) and placebo recipients in the ITT cohort. AIS: Adenocarcinoma in situ; CIN3: Grade 3 cervical intraepithelial neoplasia; ITT: Intention-to-Treat. Taken with permission from reference [21].